Skip to main content
logo
Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
429.88
-2.54 (-0.59%)
At close: Aug 31, 2026, 4:00 PM EDT
433.00
+3.12 (0.73%)
After-hours: Aug 31, 2026, 7:56 PM EDT

Amgen Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Revenue
9,5378,2189,3679,1378,7717,8738,7168,1518,0417,1187,8336,5486,6835,8466,5526,2376,2815,7316,2716,320
Other Revenue
517400499420408276370352347329363355303259287415313507575386
Revenue
10,0548,6189,8669,5579,1798,1499,0868,5038,3887,4478,1966,9036,9866,1056,8396,6526,5946,2386,8466,706
Revenue Growth (YoY)
9.53%5.75%8.58%12.40%9.43%9.43%10.86%23.18%20.07%21.98%19.84%3.77%5.95%-2.13%-0.10%-0.80%1.04%5.71%3.20%4.41%
Cost of Revenue
2,7512,4972,6762,7442,6722,6052,7122,6492,5762,5072,4561,8061,8131,7201,7471,5881,5101,5611,7181,609
Gross Profit
7,3036,1217,1906,8136,5075,5446,3745,8545,8124,9405,7405,0975,1734,3855,0925,0645,0844,6775,1285,097
Selling, General & Admin
1,7451,6021,9521,7201,6911,6871,8781,6251,7851,8081,7871,3531,2941,2581,5721,2871,3271,2281,4251,305
Research & Development
1,8681,7192,1421,9001,7441,4861,7241,4501,4471,3431,5341,0791,1131,0581,3241,1121,0399591,3481,422
Other Operating Expenses
116-11382-717730172711137-778791105-5811542--3
Operating Expenses
3,7293,2084,1763,5493,5123,2033,7743,1463,2433,1882,5433,2232,5122,3162,9542,4102,9082,1872,7732,730
Operating Income
3,5742,9133,0143,2642,9952,3412,6002,7082,5691,7523,1971,8742,6612,0692,1382,6542,1762,4902,3552,367
Interest Expense
-673-657-1,061-685-694-723-1,257-776-808-824-2,046-759-752-543-542-368-328-295-335-296
Interest & Investment Income
--408---510---1,225---127-----
Earnings From Equity Investments
-----------134153-20292-104-80-160181-98
Currency Exchange Gain (Loss)
9-775-3917283-162121-3-3199-8651-22228-198-185-78-55-104
Other Non Operating Income (Expenses)
145192143181-113-376226-1094234-26588336213-177210-4-242382319
EBT Excluding Unusual Items
3,0552,3712,5092,7212,3601,3251,9172,0431,8521,1312,3151,7702,2961,7372,0662,1941,5791,7152,5282,188
Merger & Restructuring Charges
-60-247-300-338-339-363-400-661-660-693-1,143---143-----58-
Gain (Loss) on Sale of Investments
-227-130-7011,938-5701,700-8461,719-398-57123830-7051,853-488192-48-50-346-44
Gain (Loss) on Sale of Assets
--------------62-----
Asset Writedown
----400--800129---68-783---------
Other Unusual Items
-906-117111-18--13322514723-51086-10711
Pretax Income
2,7682,0841,5143,9211,5681,9737823,101794-688521,9471,6143,4421,7482,3921,5311,6752,1312,155
Income Tax Expense
393265181705136243155271484585217235601132249214199232271
Net Income
2,3751,8191,3333,2161,4321,7306272,830746-1137671,7301,3792,8411,6162,1431,3171,4761,8991,884
Net Income to Common
2,3751,8191,3333,2161,4321,7306272,830746-1137671,7301,3792,8411,6162,1431,3171,4761,8991,884
Net Income Growth (YoY)
65.85%5.15%112.60%13.64%91.96%--18.25%63.58%-45.90%--52.54%-19.27%4.71%92.48%-14.90%13.75%183.84%-10.33%17.59%-6.78%
Shares Outstanding (Basic)
540540539538538538537537537536535535535534535535535548562567
Shares Outstanding (Diluted)
544544543542541541542542541536540538537538539538537551565570
Shares Change (YoY)
0.56%0.56%0.18%--0.93%0.37%0.74%0.74%-0.37%0.19%---2.36%-4.60%-5.61%-6.77%-5.16%-3.42%-3.23%
EPS (Basic)
4.403.372.475.982.663.221.175.271.39-0.211.433.232.585.323.024.012.462.693.383.32
EPS (Diluted)
4.373.342.465.932.653.201.165.221.38-0.211.423.222.575.282.993.982.452.683.363.31
EPS Growth (YoY)
64.91%4.38%112.07%13.60%92.03%--18.73%62.11%-46.30%--52.42%-19.10%4.90%97.02%-10.90%20.24%202.55%-5.30%21.72%-3.50%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
3,4891,4779614,2481,9119804,4003,3142,2214592892,5123,8387202,3092,8181,6841,9742,5212,176
Free Cash Flow Per Share
6.412.711.777.843.531.818.126.114.110.860.544.677.151.344.285.243.143.584.463.82
Dividend Per Share
2.5202.5202.3802.3802.3802.3802.2502.2502.2502.2502.1302.1302.1302.1301.9401.9401.9401.9401.7601.760
Dividend Growth (YoY)
5.88%5.88%5.78%5.78%5.78%5.78%5.63%5.63%5.63%5.63%9.79%9.79%9.79%9.79%10.23%10.23%10.23%10.23%10.00%10.00%
Gross Margin
72.64%71.03%72.88%71.29%70.89%68.03%70.15%68.85%69.29%66.33%70.03%73.84%74.05%71.83%74.45%76.13%77.10%74.98%74.91%76.01%
Operating Margin
35.55%33.80%30.55%34.15%32.63%28.73%28.62%31.85%30.63%23.53%39.01%27.15%38.09%33.89%31.26%39.90%33.00%39.92%34.40%35.30%
Profit Margin
23.62%21.11%13.51%33.65%15.60%21.23%6.90%33.28%8.89%-1.52%9.36%25.06%19.74%46.54%23.63%32.22%19.97%23.66%27.74%28.09%
Free Cash Flow Margin
34.70%17.14%9.74%44.45%20.82%12.03%48.43%38.97%26.48%6.16%3.53%36.39%54.94%11.79%33.76%42.36%25.54%31.64%36.82%32.45%
EBITDA
4,6864,0294,0224,5714,3363,7283,8864,1043,9693,1514,4382,7693,5572,9693,0493,4913,0043,3313,2073,217
EBITDA Margin
46.61%46.75%40.77%47.83%47.24%45.75%42.77%48.27%47.32%42.31%54.15%40.11%50.92%48.63%44.58%52.48%45.56%53.40%46.84%47.97%
D&A For EBITDA
1,1121,1161,0081,3071,3411,3871,2861,3961,4001,3991,241895896900911837828841852850
EBIT
3,5742,9133,0143,2642,9952,3412,6002,7082,5691,7523,1971,8742,6612,0692,1382,6542,1762,4902,3552,367
EBIT Margin
35.55%33.80%30.55%34.15%32.63%28.73%28.62%31.85%30.63%23.53%39.01%27.15%38.09%33.89%31.26%39.90%33.00%39.92%34.40%35.30%
Effective Tax Rate
14.20%12.72%11.96%17.98%8.67%12.32%19.82%8.74%6.04%-9.98%11.14%14.56%17.46%7.55%10.41%13.98%11.88%10.89%12.57%
Revenue as Reported
10,0548,6189,8669,5579,1798,1499,0868,5038,3887,4478,1966,9036,9866,1056,8396,6526,5946,2386,8466,706
SEC Filings: 10-K · 10-Q